Saltar para:
Logótipo
Você está em: Início > Publicações > Visualização > Neuropeptide Y expression and function during osteoblast differentiation – insights from transthyretin knockout mice

Neuropeptide Y expression and function during osteoblast differentiation – insights from transthyretin knockout mice

Título
Neuropeptide Y expression and function during osteoblast differentiation – insights from transthyretin knockout mice
Tipo
Artigo em Revista Científica Internacional
Ano
2010
Autores
Meriem Lamghari
(Autor)
Outra
A pessoa não pertence à instituição. A pessoa não pertence à instituição. A pessoa não pertence à instituição. Sem AUTHENTICUS Sem ORCID
Revista
Título: FEBS JournalImportada do Authenticus Pesquisar Publicações da Revista
Páginas: 1-13
ISSN: 1742-464X
Editora: Wiley-Blackwell
Classificação Científica
FOS: Ciências médicas e da saúde > Outras ciências médicas
Outras Informações
Resumo (PT): To better understand the role of neuropeptide Y (NPY) in bone homeostasis, as its function in the regulation of bone mass is unclear, we assessed its expression in this tissue. By immunohistochemistry, we demonstrated, both at embryonic stages and in the adult, that NPY is synthesized by osteoblasts, osteocytes, and chondrocytes. Moreover, peptidylglycine a-amidating monooxygenase, the enzyme responsible for NPY activation by amidation, was also expressed in these cell types. Using transthyretin (TTR) KO mice as a model of augmented NPY levels, we showed that this strain has increased NPY content in the bone, further validating the expression of this neuropeptide by bone cells. Moreover, the higher amidated neuropeptide levels in TTR KO mice were related to increased bone mineral density and trabecular volume. Additionally, RT-PCR analysis established that NPY is not only expressed in MC3T3-E1 osteoblastic cells and bone marrow stromal cells (BMSCs), but is also detectable by RIA in BMSCs undergoing osteoblastic differentiation. In agreement with our in vivo observations, in vitro, TTR KO BMSCs differentiated in osteoblasts had increased NPY levels and exhibited enhanced competence in undergoing osteoblastic differentiation. In summary, this work contributes to a better understanding of the role of NPY in the regulation of bone formation by showing that this neuropeptide is expressed in bone cells and that increased amidated neuropeptide content is related to increased bone mass. Abbreviations ALP, alkaline phosphatase; BMD, bone mineral density; BMSC, bone marrow stromal cell; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HPRT, hypoxanthine-guanine phosphoribosyltransferase; KO, knockout; microCT, micro computed tomography; NF200, neurofilament 200; NPY, neuropeptide Y; PAM, peptidylglycine a-amidating monooxygenase; PGP9.5, protein gene product 9.5; RANK, receptor activator of nuclear factor-jB; T4, thyroxine; TTR, transthyretin. FEBS Journal (2009) ª 2009 The Authors Journal compilation ª 2009 FEBS 1
Abstract (EN): To better understand the role of neuropeptide Y (NPY) in bone homeostasis, as its function in the regulation of bone mass is unclear, we assessed its expression in this tissue. By immunohistochemistry, we demonstrated, both at embryonic stages and in the adult, that NPY is synthesized by osteoblasts, osteocytes, and chondrocytes. Moreover, peptidylglycine a-amidating monooxygenase, the enzyme responsible for NPY activation by amidation, was also expressed in these cell types. Using transthyretin (TTR) KO mice as a model of augmented NPY levels, we showed that this strain has increased NPY content in the bone, further validating the expression of this neuropeptide by bone cells. Moreover, the higher amidated neuropeptide levels in TTR KO mice were related to increased bone mineral density and trabecular volume. Additionally, RT-PCR analysis established that NPY is not only expressed in MC3T3-E1 osteoblastic cells and bone marrow stromal cells (BMSCs), but is also detectable by RIA in BMSCs undergoing osteoblastic differentiation. In agreement with our in vivo observations, in vitro, TTR KO BMSCs differentiated in osteoblasts had increased NPY levels and exhibited enhanced competence in undergoing osteoblastic differentiation. In summary, this work contributes to a better understanding of the role of NPY in the regulation of bone formation by showing that this neuropeptide is expressed in bone cells and that increased amidated neuropeptide content is related to increased bone mass. Abbreviations ALP, alkaline phosphatase; BMD, bone mineral density; BMSC, bone marrow stromal cell; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HPRT, hypoxanthine-guanine phosphoribosyltransferase; KO, knockout; microCT, micro computed tomography; NF200, neurofilament 200; NPY, neuropeptide Y; PAM, peptidylglycine a-amidating monooxygenase; PGP9.5, protein gene product 9.5; RANK, receptor activator of nuclear factor-jB; T4, thyroxine; TTR, transthyretin. FEBS Journal (2009) ª 2009 The Authors Journal compilation ª 2009 FEBS 1
Idioma: Português
Tipo (Avaliação Docente): Científica
Contacto: lamghari@ineb.up.pt
Documentos
Não foi encontrado nenhum documento associado à publicação.
Publicações Relacionadas

Da mesma revista

New insights into cancer-related proteins provided by the yeast model (2012)
Outra Publicação em Revista Científica Internacional
Clara Pereira; Isabel Coutinho; Joana Soares; Claudia Bessa; Mariana Leao; Lucilia Saraiva
Mutagenesis of polypeptide subunits of complex I from Neurospora crassa mitochondria. (2005)
Outra Publicação em Revista Científica Internacional
Arnaldo Videira; M Duarte; I Marques; A Ushakova
Functional validation of LexDBDGim chimeras in Saccharomyces cerevisiae (2012)
Resumo de Comunicação em Conferência Internacional
amorim, a; pinto, d; fernandes, l

Ver todas (30)

Recomendar Página Voltar ao Topo
Copyright 1996-2025 © Faculdade de Medicina Dentária da Universidade do Porto  I Termos e Condições  I Acessibilidade  I Índice A-Z  I Livro de Visitas
Página gerada em: 2025-06-23 às 10:57:07 | Política de Utilização Aceitável | Política de Proteção de Dados Pessoais | Denúncias